ETHNIC VARIATIONS IN PATIENT AND GRAFT-SURVIVAL AFTER LIVER-TRANSPLANTATION - IDENTIFICATION OF A NEW RISK FACTOR FOR CHRONIC ALLOGRAFT-REJECTION

被引:38
作者
DEVLIN, JJ
OGRADY, JG
TAN, KC
CALNE, RY
WILLIAMS, R
机构
[1] KINGS COLL HOSP,INST LIVER STUDIES,LONDON SE5 9RS,ENGLAND
[2] KINGS COLL HOSP,DEPT LIVER TRANSPLANT SURG,LONDON,ENGLAND
[3] ADDENBROOKES HOSP,DEPT SURG,CAMBRIDGE CB2 2QQ,ENGLAND
关键词
D O I
10.1097/00007890-199312000-00020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ethnic origin of renal graft recipients is recognized as an important determinant of graft survival. In liver transplantation, the effect of racial origin has been studied in black American recipients and has suggested a trend toward inferior graft survival in this group. In this study, we have analyzed outcome of transplantation in a large multiethnic liver transplant program. Non-Caucasoid recipients had an inferior patient survival compared with Caucasoids and, in particular, European Caucasoids at 1, 3, and 5 years after transplantation (46.7% vs. 60.2% at 3 years, P=0.05). Non-European recipients had an inferior graft survival compared with European recipients at 1, 2, and 3 years after transplantation (e.g., north Europeans 53.5%, south Europeans 48.5%, Middle Eastern 40%, and non-Caucasoids 27% at 3 years, P<0.01). Different frequencies of chronic allograft rejection in the ethnic groups contributed to the rates of graft survival, with the non-European recipients developing chronic rejection at over twice the rate of European recipients (12.6% vs. 5.9%, respectively, P=0.002). The findings in this study support the evidence from renal transplant programs that the ethnic origin of recipients is an important determinant of outcome after transplantation, with increasing frequency of chronic rejection in recipients nonindigenous to the donor population contributing to the variations in patient and graft survival rates.
引用
收藏
页码:1381 / 1384
页数:4
相关论文
共 14 条
[1]   INFLUENCE OF POSITIVE LYMPHOCYTE CROSSMATCH AND HLA MISMATCHING ON VANISHING BILE-DUCT SYNDROME IN HUMAN-LIVER ALLOGRAFTS [J].
BATTS, KP ;
MOORE, SB ;
PERKINS, JD ;
WIESNER, RH ;
GRAMBSCH, PM ;
KROM, RAF .
TRANSPLANTATION, 1988, 45 (02) :376-379
[2]  
DONALDSON P, 1991, THERAPY LIVER DISEAS, P197
[3]  
DUNN J, 1989, TRANSPLANT P, V21, P3946
[4]   ALLELES AT 4 HLA CLASS-II LOCI DETERMINED BY OLIGONUCLEOTIDE HYBRIDIZATION AND THEIR ASSOCIATIONS IN 5 ETHNIC-GROUPS [J].
FERNANDEZVINA, MA ;
GAO, XJ ;
MORAES, ME ;
MORAES, JR ;
SALATIEL, I ;
MILLER, S ;
TSAI, J ;
SUN, YP ;
AN, JB ;
LAYRISSE, Z ;
GAZIT, E ;
BRAUTBAR, C ;
STASTNY, P .
IMMUNOGENETICS, 1991, 34 (05) :299-312
[5]  
GONWA TA, 1991, ARCH SURG-CHICAGO, V126, P1141
[6]   POSSIBLE CONTRIBUTION OF PRETRANSPLANT IMMUNE RESPONDER STATUS TO RENAL-ALLOGRAFT SURVIVAL DIFFERENCES OF BLACK VERSUS WHITE RECIPIENTS [J].
KERMAN, RH ;
KIMBALL, PM ;
VANBUREN, CT ;
LEWIS, RM ;
KAHAN, BD .
TRANSPLANTATION, 1991, 51 (02) :338-342
[7]  
Kondo K, 1987, Clin Transpl, P339
[8]  
MILGROM M, 1989, TRANSPLANT P, V21, P3934
[9]  
OGRADY JG, 1988, LANCET, V2, P302
[10]  
OPELZ G, 1989, TRANSPLANT P, V21, P3918